MedTrace Logo

A FIH Trial of the STREAMLINE™ SURGICAL SYSTEM

NCT04700189 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2023-05-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and Intraocular pressure lowering effectiveness of the Streamline™ Surgical System.

Conditions

Interventions

DEVICE

ab interno canaloplasty

A modification of traditional canaloplasty procedure. Can be combined with or done without cataract surgery.

Sponsors & Collaborators

  • New World Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Gabriel Lozcano, MD · Puebla, Mexico

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-04
Primary Completion
2022-09-21
Completion
2022-09-21
FDA Device
Yes

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04700189 on ClinicalTrials.gov